Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC)
Agency
National Institutes of Health
Posted
Aug 20, 2026
Due Date
Oct 1, 2027
Description
<p>This renewal of the Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRCs) continues a legislatively-mandated Centers of Excellence program, which aims to expand and intensify research on muscular dystrophy. The Centers advance basic, translational, and clinical muscular dystrophy research through interdisciplinary collaboration and shared resources for the research community. They support innovative, center-based projects that would be less effective as stand-alone grants, and provide strong training environments for emerging scientists. The Centers also engage patient and advocacy communities to raise research awareness, encourage participation, and ensure patient-centered perspectives inform study design and conduct. Grant authorities that allow NICHD to forecast this opportunity are as follows: 42 U.S.C. 281 (Sec. 401); 42 USC 283g (Sec. 404E); 42 U.S.C. 285g (Sec. 448); 42 USC 284h (Sec. 409D)</p>
AI Summary
Award Ceiling: 1,000,000 | Agency: National Institutes of Health
Details
- Notice ID
- 363681
- Solicitation Number
- RFA-HD-28-004
- Classification Code
- D
Want to track opportunities like this?
Sign up for Kontratar to get AI-powered opportunity matching, ranking, and alerts.
Get Started FreeRelated opportunities
- Leveraging NAMs to understand disease triggers, discover early biomarkers and develop new classes of therapeutic strategies for Type 1 Diabetes (U01 Clinical Trial Not Allowed)
National Institutes of Health
- Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not Allowed)
National Institutes of Health
- Research on System Support and Tools for Provider Training and Quality Monitoring for Suicide Preventive Care (RP1- Clinical Trial Optional)
National Institutes of Health
- Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)
National Institutes of Health
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Research Centers (U01 Clinical Trial Not Allowed)
National Institutes of Health
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) Scientific Data Research Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
- Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
National Institutes of Health
- George M. O’Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)
National Institutes of Health